AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10492858
Drug: Twice weekly
RxNorm normalized name: Alora 0.1 MG/Day Twice Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice weekly ECT
Trial: 9821454
Drug: Three times
RxNorm normalized name: WELLBUTRIN 100 MG Oral Tablet, Three Times Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three times weekly ECT
Trial: 8698227
Drug: Gastric permeability
RxNorm normalized name: gastric mucins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastric permeability measured by oral or duodenal administration of a triple sugar solution (20 g sucrose, 10 g lactulose, 5 g mannitol in 100 mL water)
Trial: 1894758
Drug: 150‐mg phenylpropanolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150‐mg phenylpropanolamine
Trial: 1894758
Drug: 75‐mg phenylpropanolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75‐mg phenylpropanolamine
Trial: 1894758
Drug: 75‐mg phenylpropanolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75‐mg phenylpropanolamine plus 400‐mg caffeine
Trial: 6225150
Drug: Zimelidine (75-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zimelidine (75-300 mg/day)
Trial: 6225150
Drug: Amitriptyline (dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (dosage not specified)
Trial: 27841155
Drug: Vilaprisan 5
RxNorm normalized name: Vilaprisan
DrugBank: Vilaprisan (DB11971)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilaprisan 5 mg
Trial: 27841155
Drug: Vilaprisan 15
RxNorm normalized name: Vilaprisan
DrugBank: Vilaprisan (DB11971)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilaprisan 15 mg
Trial: 25186261
Drug: fluticasone propionate/salmeterol
RxNorm normalized name: fluticasone propionate/salmeterol 100/50 MCG/INHAL Dry Powder Inhaler, 14 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fluticasone propionate/salmeterol combination
Trial: 8943962
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg daily
Trial: 9698952
Drug: Bupivacaine 0.12%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.12% with fentanyl 2 micrograms/ml
Trial: 9698952
Drug: Bupivacaine 0.24%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.24% with fentanyl 4 micrograms/ml
Trial: 28661759
Drug: Epirubicin (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin (90 mg/m2) and cyclophosphamide (600 mg/m2) followed by docetaxel (100 mg/m2; EC-D)
Trial: 28661759
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg/m2) and cyclophosphamide (600 mg/m2; DC)
Trial: 25937436
Drug: Sofosbuvir 400
RxNorm normalized name: sofosbuvir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir 400 mg and ribavirin 1000-1200 mg daily for 24 weeks
Trial: 25937436
Drug: Sofosbuvir 400
RxNorm normalized name: sofosbuvir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir 400 mg and ribavirin 1000-1200 mg daily for 12 weeks
Trial: 25937436
Drug: Sofosbuvir 400
RxNorm normalized name: sofosbuvir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir 400 mg and ribavirin for 24 weeks in patients with cirrhosis
Trial: 16775230
Drug: subcutaneous interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: subcutaneous interferon beta‐1a at 22 mug, three times weekly
Trial: 12959273
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS (60 mg)
Trial: 18306163
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Er:YAG laser ablation and ALA methyl ester PDT (method C)
Trial: 18306163
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) only (method A)
Trial: 11994041
Drug: Fluconazole 150
RxNorm normalized name: fluconazole 150 MG
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 150 mg once weekly for 12 weeks
Trial: 11994041
Drug: Fluconazole 150
RxNorm normalized name: fluconazole 150 MG
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 150 mg once weekly for 24 weeks
Trial: 2121846
Drug: Praziquantel (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel (40 mg/kg orally every 6 months)
Trial: 2121846
Drug: Praziquantel (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel (initial full dose of 40 mg/kg followed by 20 mg/kg every 3 months)
Trial: 2121846
Drug: Praziquantel (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel (initial loading dose followed by 20 mg/kg at monthly intervals)
Trial: 2121846
Drug: Praziquantel (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel (20 mg/kg orally every 3 months)
Trial: 2121846
Drug: Placebo (vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vitamin B complex tablets at 3-month intervals)
Trial: 2121846
Drug: Praziquantel (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel (20 mg/kg orally monthly for urinary hematobiasis)
Trial: 2121846
Drug: Placebo (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (two vitamin B-complex tablets monthly for urinary hematobiasis)
Trial: 31190359
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (1,000 mg omega-3 fatty acids, twice a day for 12 weeks)
Trial: 24304731
Drug: Metformin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1 g/day) for 12 weeks
Trial: 21729238
Drug: Levothyroxine 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levothyroxine 0.3 mg per day
Trial: 16409456
Drug: 9000 aXa-units
RxNorm normalized name: Axatilimab
DrugBank: Axatilimab (DB16388)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9000 aXa-units of unfractionated heparin (UFH)
Trial: 15354517
Drug: Antibiotic prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylaxis (Group B)
Trial: 15354517
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Group D)
Trial: 10954344
Drug: Oral cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cocaine administration
Trial: 1729427
Drug: Intravenous cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cocaine administration
Trial: 8859258
Drug: Furosemide (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (2 mg/kg) in patients with HPS
Trial: 8859258
Drug: Furosemide therapy
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide therapy in patients with HPS
Trial: 8859258
Drug: Furosemide therapy
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide therapy in healthy children
Trial: 9387348
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (Group A)
Trial: 17400981
Drug: Fast injection
RxNorm normalized name: Fast Freeze
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fast injection (over four seconds, Group F) of 0.75% hyperbaric bupivacaine 12 mg plus morphine 200 microg
Trial: 17400981
Drug: Slow injection
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow injection (over 40 seconds, Group S) of 0.75% hyperbaric bupivacaine 12 mg plus morphine 200 microg
Trial: 12175715
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate (IMN) 40 mg vaginally
Trial: 25163444
Drug: 3‐mg melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3‐mg melatonin
Trial: 25163444
Drug: 5‐mg melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐mg melatonin
Trial: 15894688
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with 63 g of sugars for 10 days
Trial: 15894688
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with 143 g of sugars for 10 days
Trial: 15894688
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with 264 g of sugars for 10 days
Trial: 7095978
Drug: Intranasal cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal cocaine hydrochloride (0.75 mg/kg)
Trial: 7095978
Drug: Intranasal cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal cocaine hydrochloride (1.5 mg/kg)
Trial: 7095978
Drug: Intranasal lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal lidocaine hydrochloride (0.2 mg/kg)
Trial: 31399906
Drug: Apatinib 250
RxNorm normalized name: lapatinib 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apatinib 250 mg/day during chemotherapy interval and as maintenance therapy
Trial: 31614909
Drug: Eyewash solution
DrugBank: Boric acid (DB11326)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eyewash solution (preservative-free)
Trial: 23660289
Drug: Intra-arterial tirofiban
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial tirofiban infusion
Trial: 30669797
Drug: Parecoxib (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parecoxib (40 mg)
Trial: 21354925
Drug: PCA with
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA with morphine doses at 0 mg (P(1))
Trial: 21354925
Drug: PCA with
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA with morphine doses at 5 mg (P(2))
Trial: 21354925
Drug: PCA with
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA with morphine doses at 10 mg (P(3))
Trial: 21354925
Drug: PCA with
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA with morphine doses at 15 mg (P(4))
Trial: 21354925
Drug: PCA with
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA with morphine doses at 20 mg (P(5))
Trial: 17556628
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of azithromycin, ivermectin, and albendazole
Trial: 17556628
Drug: Ivermectin and
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin and albendazole combination
Trial: 15167732
Drug: Preincisional retrobulbar
RxNorm normalized name: bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preincisional retrobulbar injection containing bupivacaine, lidocaine, epinephrine, and hyaluronidase
Trial: 11677191
Drug: Cholestyramine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine treatment for 2 weeks
Trial: 11677191
Drug: Cholestyramine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholestyramine treatment in patients with elevated cholesterol levels
Trial: 7786693
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate therapy (1.0 g bolus followed by 1.0 g every hour for three hours, then 1.0 g every 6 hours for 24 hours)
Trial: 7786693
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no magnesium sulphate therapy)
Trial: 3057900
Drug: Anti-cholera toxin
RxNorm normalized name: VIBRIO CHOLERAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-cholera toxin bovine colostral immunoglobulins (2 g in 100 ml of water, two doses in Trial I; 2 g every two hours for a total of eight doses in Trial II)
Trial: 3057900
Drug: Non-immune bovine
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-immune bovine colostral immunoglobulins (two doses in Trial I; 2 g every two hours for a total of eight doses in Trial II)
Trial: 3057900
Drug: Water (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water (100 ml alone in Trial I; 100 ml every two hours for a total of eight doses in Trial II)
Trial: 19959168
Drug: Miglustat therapy
RxNorm normalized name: Miglustat
DrugBank: Miglustat (DB00419)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Miglustat therapy
Trial: 10534727
Drug: Recombinant hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hepatitis B vaccine (20 microg/dose) given in months 0, 1, and 6 to group II (35 healthy subjects)
Trial: 7785755
Drug: Isoflurane anesthesia
RxNorm normalized name: Isoflurane
DrugBank: Isoflurane (DB00753)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoflurane anesthesia (methohexital 1-2 mg/kg for induction, isoflurane 0.4-2.0 vol% for maintenance)
Trial: 9734576
Drug: Adjuvant psychological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant psychological group therapy
Trial: 8291822
Drug: Doxycycline, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline, 100 mg, once daily
Trial: 3397588
Drug: iso-osmolar test
RxNorm normalized name: iso-sulfan blue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iso-osmolar test solutions
Trial: 3397588
Drug: hyperosmolar test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hyperosmolar test solutions
Trial: 3397588
Drug: D-xylose absorption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-xylose absorption
Trial: 3397588
Drug: lactulose and
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: lactulose and L-rhamnose permeation
Trial: 21507036
Drug: Topical PUVAsol
RxNorm normalized name: docusate sodium / sennosides, USP Oral Tablet [Purgasol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical PUVAsol on alternate days for 16 weeks
Trial: 21727006
Drug: Ibandronate 6
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 6 mg infused over 15 min
Trial: 16703289
Drug: Xerostomia group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xerostomia group (salivary flow < 0.2 ml/min)
Trial: 16703289
Drug: Nonxerostomia group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonxerostomia group (salivary flow > 0.2 ml/min)
Trial: 10718161
Drug: Weekly relapse
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly relapse prevention therapy
Trial: 3498281
Drug: Combination heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combination heat supply group (12 patients)
Trial: 18472087
Drug: Demineralisation solution
RxNorm normalized name: Mineral Oil
DrugBank: Mineral oil (DB11057)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Demineralisation solution with 1 ppm fluoride for five days
Trial: 9621483
Drug: EPI (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPI (160 mg/m2 i.v. every 3 weeks)
Trial: 3279968
Drug: Acipimox 750
RxNorm normalized name: acipimox
DrugBank: Acipimox (DB09055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox 750 mg/day for first 6 months, then 1200 mg/day for last 3 months
Trial: 30673687
Drug: Individualized exercise
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized exercise prescription
Trial: 30673687
Drug: Standardized exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized exercise prescription
Trial: 21178179
Drug: Ewes fed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ewes fed ASe (3.05 μg/kg of BW)
Trial: 21178179
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Se treatment and late gestation nutritional level
Trial: 19500346
Drug: Stepped care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepped care program consisting of Watchful waiting, Guided self-help, Problem Solving Treatment, Medication and/or specialized mental health care
Trial: 14765861
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous sulphate for six weeks
Trial: 11739066
Drug: Carbamazepine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (400 mg/day)
Trial: 3284549
Drug: Defibrinogenation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Defibrinogenation therapy
Trial: 22050040
Drug: Brimonidine tartrate
RxNorm normalized name: Brimonidine Tartrate
DrugBank: Brimonidine (DB00484)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Brimonidine tartrate (BT) 0.5% once daily
Trial: 22050040
Drug: Brimonidine tartrate
RxNorm normalized name: Brimonidine Tartrate
DrugBank: Brimonidine (DB00484)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Brimonidine tartrate (BT) 0.18% once daily
Trial: 28095573
Drug: Vehicle once
RxNorm normalized name: gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vehicle once daily
Trial: 22050040
Drug: Brimonidine tartrate
RxNorm normalized name: Brimonidine Tartrate
DrugBank: Brimonidine (DB00484)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Brimonidine tartrate (BT) 0.18% twice daily
Trial: 18279480
Drug: Antibacterial agents
RxNorm normalized name: Dermoplast Antibacterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibacterial agents RCTs
Trial: 10220833
Drug: No medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No medication or nonsteroidal antirheumatic drugs
Trial: 8935108
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of enamel etching and dentinal bonding (n = 188)
Trial: 12675
Drug: Injectable combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injectable combination of local anaesthetic (Xylestesin) and beta-receptor-blocker (Betadrenol)
Trial: 27732968
Drug: Paclitaxel (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (standard dose and schedule)
Trial: 23948958
Drug: High-dose statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose statin therapy
Trial: 12519653
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg arecoline
Trial: 12519653
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg arecoline
Trial: 12519653
Drug: Areca nut
RxNorm normalized name: Areca catechu seed extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Areca nut (various doses)
Trial: 9086386
Drug: Sequential compression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential compression device (SCD + TED)
Trial: 8460756
Drug: Omeprazole 80
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 80 mg + Metoclopramide 10 mg (group 4)
Trial: 8460756
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg (group 1)
Trial: 8460756
Drug: Omeprazole 80
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 80 mg (group 2)
Trial: 8460756
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg + Metoclopramide 10 mg (group 3)
Trial: 3956895
Drug: 20 min
RxNorm normalized name: wheat germ oil 20 minim ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 min daily bicycle exercise
Trial: 23194486
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous diuretics
Trial: 23194486
Drug: Bolus intravenous
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus intravenous diuretics
Trial: 23194486
Drug: High initial
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High initial intravenous diuretic dose
Trial: 23194486
Drug: Low initial
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low initial intravenous diuretic dose
Trial: 23194486
Drug: High outpatient
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High outpatient diuretic doses
Trial: 23194486
Drug: Low outpatient
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low outpatient diuretic doses
Trial: 23194486
Drug: Mode of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mode of therapy (bolus vs continuous)